AngioDynamics, Inc.  

(Public, NASDAQ:ANGO)   Watch this stock  
Find more results for ANGO
16.73
-0.11 (-0.68%)
After Hours: 16.73 0.00 (0.00%)
Feb 22, 4:00PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.67 - 17.21
52 week 14.80 - 18.85
Open 16.93
Vol / Avg. 115,318.00/241,750.00
Mkt cap 614.75M
P/E     -
Div/yield     -
EPS -0.27
Shares 36.75M
Beta 0.98
Inst. own 101%
Mar 28, 2018
Q3 2018 AngioDynamics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 13, 2018
AngioDynamics Inc at Barclays Global Healthcare Conference - 3:20PM EDT - Add to calendar
Jan 10, 2018
AngioDynamics Inc at JPMorgan Healthcare Conference - Q&A
Jan 10, 2018
AngioDynamics Inc at JPMorgan Healthcare Conference - Webcast
Jan 4, 2018
Q2 2018 AngioDynamics Inc Earnings Release
Jan 4, 2018
Q2 2018 AngioDynamics Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Nov '17) 2017
Net profit margin 0.29% 1.43%
Operating margin 1.30% 3.71%
EBITD margin - 18.67%
Return on average assets 0.14% 0.70%
Return on average equity 0.19% 0.98%
Employees 1,250 -
CDP Score - -

Address

14 Plaza Dr
LATHAM, NY 12110-2166
United States - Map
+1-518-7981215 (Phone)
+1-518-7951401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Officers and directors

Howard W. Donnelly Independent Chairman of the Board
Age: 56
Bio & Compensation  - Reuters
James C. Clemmer President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Michael C. Greiner Chief Financial Officer, Executive Vice President, IR Contact Officer
Age: 44
Bio & Compensation  - Reuters
Robert A. Simpson Senior Vice President and General Manager, Peripheral Vascular
Age: 45
Bio & Compensation  - Reuters
Heather J. Daniels-Cariveau Senior Vice President of Human Resources
Age: 43
Bio & Compensation  - Reuters
Gary Barrett Senior Vice President,Quality and Regulatory Affairs
Age: 47
Bio & Compensation  - Reuters
Chad T. Campbell Senior Vice President and General Manager, Vascular Access
Age: 46
Bio & Compensation  - Reuters
Benjamin Davis Senior Vice President, Business Development
Age: 52
Bio & Compensation  - Reuters
Barbara A. Kucharczyk Senior Vice President-Global Operations
Age: 44
Bio & Compensation  - Reuters
Warren G. Nighan Senior Vice President-Senior Vice President Quality & Regulatory Affairs
Age: 48
Bio & Compensation  - Reuters